Deracoxib

Also known as: 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide, Benzenesulfonamide, 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-, Deramaxx, SC-46, SC-046, SC-59046, UNII-VX29JB5XWV

Deracoxib (CAS 169590-41-4) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C17H14F3N3O3S and a molecular weight of 397.372 g/mol. Key properties include a boiling point of 575.5±60.0 °C at 760 mmHg, a density of 1.5±0.1 g/cm3 and a flash point of 301.9±32.9 °C. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 169590-41-4
Jingsj CID: J-1957144-9
Molecular Formula: C₁₇H₁₄F₃N₃O₃S
Molecular Weight: 397.372 g/mol
Category: Organic Compounds
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Boiling Point	575.5±60.0 °C at 760 mmHg
Density	1.5±0.1 g/cm3
Flash Point	301.9±32.9 °C
Exact Mass	397.070801
PSA	95.59000
LogP	2.54
Vapor Pressure	0.0±1.6 mmHg at 25°C
Refractive Index	1.610
Storage Conditions	-20℃

Activity & Biological Data

Target	COX-2
Additional Information	[1]. Royals, S.R., et al., Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs. Am J Vet Res, 2005. 66(11): p. 1961-7. [2]. Ustun Alkan, F., et al., The effects of piroxicam and deracoxib on canine mammary tumour cell line. ScientificWorldJournal, 2012. 2012: p. 976740. [3]. Bienhoff, S.E., et al., Efficacy and safety of deracoxib for control of postoperative pain and inflammation associated with soft tissue surgery in dogs. Vet Surg, 2012. 41(3): p. 336-44. [4]. McMillan, S.K., et al., Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc, 2011. 239(8): p. 1084-9.

Target

COX-2

Additional Information

[1]. Royals, S.R., et al., Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs. Am J Vet Res, 2005. 66(11): p. 1961-7. [2]. Ustun Alkan, F., et al., The effects of piroxicam and deracoxib on canine mammary tumour cell line. ScientificWorldJournal, 2012. 2012: p. 976740. [3]. Bienhoff, S.E., et al., Efficacy and safety of deracoxib for control of postoperative pain and inflammation associated with soft tissue surgery in dogs. Vet Surg, 2012. 41(3): p. 336-44. [4]. McMillan, S.K., et al., Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc, 2011. 239(8): p. 1084-9.

Customs & Trade Information

HS Code	2935009090
Summary	2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Frequently Asked Questions

What is the CAS number of Deracoxib?

The CAS number of Deracoxib is 169590-41-4.

What are the molecular formula and molecular weight of Deracoxib?

Deracoxib has molecular formula C17H14F3N3O3S and molecular weight 397.372 g/mol.

What are the upstream and downstream products of Deracoxib?

For Deracoxib, Upstream Products: 4-Hydrazinobenzene-1-sulfonamide hydrochloride, Ethyl difluoroacetate, 3'-Fluoro-4'-methoxyacetophenone.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Deracoxib (CAS 169590-41-4)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1957144-9 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.